BML Investment Partners, L.P. - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Achilles Therapeutics plc (ACHL)

Filing Manager: BML Investment Partners, L.P.
Reporting Manager: BML Investment Partners, L.P.
Security: Achilles Therapeutics plc American Depositary Shares, each representing one ordinary share, nominal value of 0.001 per share
Symbol: ACHL
Shares outstanding: 41.1M shares
Disclosed Ownership: 4.1M shares
Ownership: 9.97%
Form type: SCHEDULE 13G/A
Date filed: 2/13/2025, 05:02 PM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BML Investment Partners, L.P.	9.97%	4.1M	0	4.1M	Braden M Leonard	BML Capital Management, LLC its General Partner By: Braden M Leonard, its Managing Member